We are live on
!
Find out more
CC
ClearArc Capital Portfolio holdings
AUM
$257M
1-Year Est. Return
33.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
–
AUM
$663M
AUM Growth
-$73.7M
(-10%)
Cap. Flow
-$65.5M
Cap. Flow
% of AUM
-9.88%
Top 10 Holdings %
Top 10 Hldgs %
19.01%
Holding
473
New
10
Increased
267
Reduced
183
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$3.03M |
| 2 |
CME Group
CME
|
+$2.88M |
| 3 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$1.23M |
| 4 |
Simon Property Group
SPG
|
+$653K |
| 5 |
Air Products & Chemicals
APD
|
+$500K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$11.2M |
| 2 |
Citigroup
C
|
+$6.24M |
| 3 |
Prologis
PLD
|
+$4.05M |
| 4 |
Boeing
BA
|
+$4.04M |
| 5 |
Home Depot
HD
|
+$3.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.01% |
| 2 | Financials | 16.05% |
| 3 | Healthcare | 13.23% |
| 4 | Industrials | 9.75% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Colgate-Palmolive
CL
$74.4B
| $1.6M | 0.24% |
22,358
-6
| -0% | -$432 |
|
|
SCHW
102
Charles Schwab
SCHW
$187B
| $1.6M | 0.24% |
30,608
+237
| +0.8% | +$12.7K |
|
103
Mondelez International
MDLZ
$79.9B
| $1.58M | 0.24% |
37,963
-77
| -0.2% | -$3.35K |
|
104
Micron Technology
MU
$991B
| $1.54M | 0.23% |
29,533
+194
| +0.7% | +$9.29K |
|
|
CELG
105
DELISTED
Celgene Corp
CELG
| $1.53M | 0.23% |
17,115
-798
| -4% | -$76.6K |
|
106
Applied Materials
AMAT
$428B
| $1.49M | 0.23% |
26,840
-305
| -1% | -$17K |
|
107
Charter Communications
CHTR
$18.2B
| $1.47M | 0.22% |
4,727
-229
| -5% | -$80.5K |
|
108
Elevance Health
ELV
$85.5B
| $1.43M | 0.22% |
6,522
+8
| +0.1% | +$1.88K |
|
|
WBA
109
DELISTED
Walgreens Boots Alliance
WBA
| $1.42M | 0.21% |
21,758
-373
| -2% | -$26.7K |
|
|
AET
110
DELISTED
Aetna Inc
AET
| $1.41M | 0.21% |
8,367
+69
| +0.8% | +$12.4K |
|
111
General Dynamics
GD
$106B
| $1.39M | 0.21% |
6,292
-8,853
| -58% | -$1.93M |
|
112
Duke Energy
DUK
$97.3B
| $1.38M | 0.21% |
17,871
+62
| +0.3% | +$4.79K |
|
113
Northrop Grumman
NOC
$81.2B
| $1.38M | 0.21% |
3,946
-17
| -0.4% | -$5.69K |
|
114
Danaher
DHR
$144B
| $1.37M | 0.21% |
15,757
+80
| +0.5% | +$7K |
|
|
115
Air Products & Chemicals
APD
$67.6B
| $1.36M | 0.21% |
8,568
+3,035
| +55% | +$500K |
|
|
BNY
116
Bank of New York Mellon
BNY
$107B
| $1.33M | 0.2% |
25,769
-281
| -1% | -$15.6K |
|
117
Becton Dickinson
BDX
$48.2B
| $1.32M | 0.2% |
6,230
-60
| -1% | -$13.1K |
|
118
TJX Companies
TJX
$178B
| $1.32M | 0.2% |
32,278
-112
| -0.3% | -$4.43K |
|
119
Biogen
BIIB
$30.7B
| $1.31M | 0.2% |
4,799
+12
| +0.3% | +$3.73K |
|
|
MON
120
DELISTED
Monsanto Co
MON
| $1.31M | 0.2% |
11,242
+58
| +0.5% | +$6.98K |
|
121
Ameriprise Financial
AMP
$48.8B
| $1.31M | 0.2% |
8,831
-16,030
| -64% | -$2.61M |
|
|
ATVI
122
DELISTED
Activision Blizzard
ATVI
| $1.31M | 0.2% |
19,364
+114
| +0.6% | +$8.05K |
|
123
Illinois Tool Works
ITW
$84.5B
| $1.29M | 0.2% |
8,253
-19,489
| -70% | -$3.24M |
|
124
Automatic Data Processing
ADP
$108B
| $1.28M | 0.19% |
11,301
+4
| +0% | +$466 |
|
125
Deere & Co
DE
$168B
| $1.28M | 0.19% |
8,255
+126
| +2% | +$20.4K |
|
Similar funds
BO
GCA
QCM
AEPI
AC
LA
JFM
SHA
ClearArc Capital's Q1 2018 Portfolio in Review
As of Q1 2018, ClearArc Capital held 473 positions worth $663M, down 10% from $736M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
ClearArc Capital withdrew a net $65.5M in Q1 2018, closing 10 positions and reducing 183 holdings. Its most notable exit was Tractor Supply, an estimated $237K position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ClearArc Capital opened a new position in Nektar Therapeutics worth $438K.
- ClearArc Capital's largest Q1 2018 buy was Nektar Therapeutics: 275 shares worth $438K.
- ClearArc Capital added most to Abbott in Q1 2018, an estimated $3.03M increase.
- ClearArc Capital's biggest Q1 2018 reduction was iShares MSCI Japan ETF, cutting an estimated $11.2M.
- ClearArc Capital fully exited Tractor Supply in Q1 2018, selling an estimated $237K.
- ClearArc Capital's ten largest holdings make up 19% of its $663M portfolio in Q1 2018.
- ClearArc Capital opened 10 new positions and closed 10 in Q1 2018.
- ClearArc Capital's portfolio value fell 10% quarter-over-quarter to $663M.
Based on ClearArc Capital's 13F filing for Q1 2018, filed 15 May 2018.